Search by Drug Name or NDC
NDC 62135-0618-12 Diphenoxylate hydrochloride and atropine sulfate .025; 2.5 mg/1; mg/1 Details
Diphenoxylate hydrochloride and atropine sulfate .025; 2.5 mg/1; mg/1
Diphenoxylate hydrochloride and atropine sulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE.
MedlinePlus Drug Summary
Diphenoxylate is used along with other treatments such as fluid and electrolyte replacement for the treatment of diarrhea. Diphenoxylate should not be given to children younger than 2 years of age. Diphenoxylate is in a class of medications called antidiarrheal agents. It works by decreasing activity of the bowel.
Related Packages: 62135-0618-12Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Diphenoxylate
Product Information
| NDC | 62135-0618 |
|---|---|
| Product ID | 62135-618_06fe1d81-11d3-f403-e063-6394a90ad65f |
| Associated GPIs | 47100010100310 |
| GCN Sequence Number | 002841 |
| GCN Sequence Number Description | diphenoxylate HCl/atropine TABLET 2.5-.025MG ORAL |
| HIC3 | D6D |
| HIC3 Description | ANTIDIARRHEALS |
| GCN | 65030 |
| HICL Sequence Number | 001235 |
| HICL Sequence Number Description | DIPHENOXYLATE HCL/ATROPINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Diphenoxylate hydrochloride and atropine sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Diphenoxylate hydrochloride and atropine sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | .025; 2.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | CV |
| Marketing Category | ANDA |
| Application Number | ANDA207128 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0618-12 (62135061812)
| NDC Package Code | 62135-618-12 |
|---|---|
| Billing NDC | 62135061812 |
| Package | 120 TABLET in 1 BOTTLE (62135-618-12) |
| Marketing Start Date | 2022-06-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.20815 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis